IMAGE-HF: Project IIa Canadian CArdiomyopathy Registry for Device Therapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

502 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-10-11

Study Completion Date

2023-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Delayed enhanced MRI in patients (of either ischemic or non-ischemic cause) being referred for primary prevention ICD

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

IMAGE-HF Project I-A: Cardiac Imaging in Ischemic Heart Failure (AIMI-HF)

NCT01288560

Heart Failure Coronary Artery Disease Ischemic Cardiomyopathy

COMPLETED NA

Routine vs Selective Cardiac Magnetic Resonance in Non-Ischemic Heart Failure

NCT01281384

Heart Failure

COMPLETED NA

Cardiovascular Imaging Registry of Canada

NCT04367220

Cardiovascular Diseases

RECRUITING

Cardiac MRI for Metal on Metal Hip Resurfacing

NCT02892448

Cardiomyopathy

COMPLETED NA

Noninvasive Imaging of Heart Failure: A Pilot Study

NCT01160471

MRI Acquired Heart Disease Myocardial Fibrosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Device therapy using defibrillators and cardiac resynchronization therapy (CRT) is an important advance in the care of patients with acquired heart disease and heart failure. In specific groups these devices appear to significantly reduce the risk of sudden cardiac death and progression of heart failure. However, our ability to identify ideal candidates, and those who are most likely to respond and benefit from this therapy, is poor.

Preliminary studies using specialized Magnetic Resonance Imaging (MRI) appears to be one of the more valuable ways of predicting response to device therapy and holds substantial promise for patients with cardiomyopathy.

Large, prospective registries are necessary to explore its real-world utility for risk prediction across a broad spectrum of patients. Can-CARD MR is a national, multi-centre registry designed to address this particular need.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* .Any patient accepted for primary prevention ICD (+/-) CRT)

Exclusion Criteria

* Known contra-indications to MRI.
* Recent myocardial infarction or revascularization procedure within the past 3 months.
* GFR (glomerular filtration rate) ≤ 30 ml. / min/ m2.

Eligible Sex

ALL

Accepts Healthy Volunteers

No